W. R. Berkley reports 0% stake in Alphavest
W. R. Berkley Corporation filed Amendment No. 1 to a Schedule 13G regarding Alphavest Acquisition Corp ordinary shares, par value $0.0001 per share (CUSIP G0283A108).
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
W. R. Berkley Corporation filed Amendment No. 1 to a Schedule 13G regarding Alphavest Acquisition Corp ordinary shares, par value $0.0001 per share (CUSIP G0283A108). The filing reports that W. R. Berkley Corporation and its subsidiary Berkley Insurance Company now beneficially own 0 shares, representing 0% of this class, with no sole or shared voting or dispositive power.
Key Figures
Key Terms
beneficially owned financial
sole voting power financial
dispositive power financial
parent holding company financial
Schedule 13G regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does W. R. Berkley’s Schedule 13G/A report for Alphavest Acquisition Corp (AMCI)?
Which securities of Alphavest Acquisition Corp (AMCI) are covered in this Schedule 13G/A?
What percentage of Alphavest Acquisition Corp (AMCI) does W. R. Berkley now report owning?
What is Berkley Insurance Company’s reported ownership in Alphavest (AMCI)?
AI-generated analysis. How Rhea-AI works. Not financial advice.